Multi-regional transcriptomic profiling reveals divergent molecular mechanisms in ALS-related neurodegeneration
PLOS Genetics · 08.07.2026 · 22 (7) · e1012225
DOI: 10.1371/journal.pgen.1012225 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Genetics, online erschienen am 08.07.2026. Verfasst von Yu-Wen Hsu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of …. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, C9orf72 Protein, Transcriptome. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Institute of Health, the Walder Foundation.
Abstract (Originalsprache)
Neurodegenerative disorders including amyotrophic lateral sclerosis (ALS) remain largely unsolved, with complex etiology yet to be fully elucidated. The most common genetic cause of ALS in both familial and sporadic cases is the expansion of a hexanucleotide repeat in the C9orf72 gene. To systematically dissect the molecular landscape of ALS, we performed integrative transcriptomic analyses across multiple central nervous system regions from ALS patients carrying pathological C9orf72 repeat expansions (ALS-C9) and those without the mutation (ALS-non-C9). In parallel, we performed transcriptome-wide cell-type deconvolution to assess the cellular composition of neuronal and non-neuronal populations. We identified a set of dysregulated molecular pathways that were consistently altered in both ALS-C9 and ALS-non-C9 patients, suggesting shared pathogenic mechanisms. Distinct gene-specific alterations also pointed to divergent subtype-dependent molecular trajectories. Gene-specific alterations were also associated with short clinical duration in ALS-non-C9, highlighting a sex-dependent immunological contribution to disease outcome. Our cross-regional integrative transcriptomic analyses reveal both convergent and divergent molecular and cellular features between ALS-C9 and ALS-non-C9 subgroups, underscoring the clinical heterogeneity of ALS and providing a framework for subtype- and sex-specific therapeutic stratifications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America.
- Department of Neuroscience, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
ORCID-Profile: Yu-Wen Hsu, Yu-Ning Lu, Mingming Liu, Jiou Wang
Förderung
- NINDS NIH HHS
- National Institute of Health
- the Walder Foundation
- The Packard Center for ALS Research at Johns Hopkins
- Maryland Stem Cell Research Fund
Zitieren
APA
Hsu, Y. W., Lu, Y. N., Liu, M., & Wang, J. (2026). Multi-regional transcriptomic profiling reveals divergent molecular mechanisms in ALS-related neurodegeneration. PLOS Genetics, 22(7), e1012225. https://doi.org/10.1371/journal.pgen.1012225
Vancouver
Hsu YW, Lu YN, Liu M, Wang J. Multi-regional transcriptomic profiling reveals divergent molecular mechanisms in ALS-related neurodegeneration. PLOS Genetics. 2026;22(7):e1012225. doi:10.1371/journal.pgen.1012225
BibTeX
@article{Hsu2026,
author = {Hsu, Yu-Wen and Lu, Yu-Ning and Liu, Mingming and Wang, Jiou},
title = {Multi-regional transcriptomic profiling reveals divergent molecular mechanisms in ALS-related neurodegeneration},
journal = {PLOS Genetics},
year = {2026},
volume = {22},
number = {7},
pages = {e1012225},
doi = {10.1371/journal.pgen.1012225}
}
EUVIMED